Literature DB >> 2653943

Human liver cell transplantation. Prolonged function in athymic-Gunn and athymic-analbuminemic hybrid rats.

A D Moscioni1, J Roy-Chowdhury, R Barbour, L L Brown, N Roy-Chowdhury, L S Competiello, P Lahiri, A A Demetriou.   

Abstract

Isolated cryopreserved human liver cells, attached to collagen-coated microcarriers, were injected intraperitoneally into mutant rat recipients genetically deficient in either bilirubin uridine diphosphoglucuronosyltransferase activity (Gunn rats) or albumin synthesis (Nagase analbuminemic rats). One group of the recipient Gunn and analbuminemic rats were made genetically immunodeficient by interbreeding with athymic rats with inherited T-cell deficiency. Injected microcarriers and cells formed aggregates on the surface of the pancreas. There was no morphologic evidence of rejection in athymic recipients, whereas immunocompetent recipients demonstrated rejection within 5 days of transplantation. Athymic-Gunn rat recipients demonstrated excretion of bilirubin glucuronides in bile for 30 days and reduction in their serum bilirubin levels. In recipient athymic-analbuminemic rats, plasma albumin levels increased from pretransplantation levels of 0.025-0.05 mg/ml to 3.9-4.8 mg/ml 8 days posttransplantation and remained nearly at that level throughout the 30 days of the study. A method of harvesting, attaching to microcarriers, cryopreserving, and in vivo testing of human hepatocytes with prolonged survival and function in athymic-Gunn and athymic-analbuminemic hybrid rats is reported. These rats are excellent animal models for testing xenograft function.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2653943

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  11 in total

1.  Transplantation of primary and reversibly immortalized human liver cells and other gene therapies in acute liver failure and decompensated chronic liver disease.

Authors:  Stephen M Riordan; Roger Williams
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

Review 2.  Cellular transplantation and gene therapy.

Authors:  C Ricordi; S T Ildstad; T E Starzl
Journal:  Clin Transplant       Date:  1993-02       Impact factor: 2.863

3.  Survival of human hepatocellular aggregates in athymic mice.

Authors:  C Ricordi; Y Zeng; B Carr; P Carroll; H L Rilo; A J Demetris; R Alejandro; D R Bereiter; J J Fung; A Tzakis
Journal:  Transplant Proc       Date:  1992-06       Impact factor: 1.066

4.  Evidence that canine pancreatic islets promote the survival of human hepatocytes in nude mice.

Authors:  C Ricordi; Y Zeng; A Tzakis; R Alejandro; A J Demetris; J Fung; D R Bereiter; D H Mintz; T E Starzl
Journal:  Transplantation       Date:  1991-10       Impact factor: 4.939

Review 5.  Hepatocyte transplantation. A potential treatment for liver disease.

Authors:  A A Demetriou; A Felcher; A D Moscioni
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

Review 6.  Isolated hepatocytes: use in experimental and clinical hepatology.

Authors:  A J Strain
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

7.  Correction of congenital hyperbilirubinemia in homozygous Gunn rats by xenotransplantation of hamster livers.

Authors:  Yoshitaka Wakizaka; Toshio Miki; Abdul S Rao; Xue Wang; April L Goller; Anthony J Demetris; John J Fung; Thomas E Starzl; Luis A Valdivia
Journal:  Xenotransplantation       Date:  1997-11-01       Impact factor: 3.907

Review 8.  Experimental hepatocyte xenotransplantation--a comprehensive review of the literature.

Authors:  Huidong Zhou; Hong Liu; Mohamed Ezzelarab; Eva Schmelzer; Yi Wang; Jörg Gerlach; Bruno Gridelli; David K C Cooper
Journal:  Xenotransplantation       Date:  2015-05-07       Impact factor: 3.907

9.  Hepatocyte transplantation improves phenotype and extends survival in a murine model of intermediate maple syrup urine disease.

Authors:  Kristen J Skvorak; Harbhajan S Paul; Kenneth Dorko; Fabio Marongiu; Ewa Ellis; Donald Chace; Carolyn Ferguson; K Michael Gibson; Gregg E Homanics; Stephen C Strom
Journal:  Mol Ther       Date:  2009-05-12       Impact factor: 11.454

10.  The history and use of human hepatocytes for the treatment of liver diseases: the first 100 patients.

Authors:  Marc C Hansel; Roberto Gramignoli; Kristen J Skvorak; Kenneth Dorko; Fabio Marongiu; William Blake; Julio Davila; Stephen C Strom
Journal:  Curr Protoc Toxicol       Date:  2014-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.